A limited study on the use of kanamycin in patients with fibrocystic diseases of the pancreas.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D003550:Cystic Fibrosis / Q000628:therapy*; D003879:Dermatologic Agents; D006801:Humans; D007612:Kanamycin; D010179:Pancreas
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D007612:Kanamycin
ANTIBIOTICS/therapeutic use; CYSTIC FIBROSIS OF PANCREAS/therapy